The artificial kidney market size has grown rapidly in recent years. It will grow from $11.43 billion in 2025 to $12.91 billion in 2026 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to increasing prevalence of end-stage renal disease, expansion of dialysis treatment centers, advancements in dialysis membrane technology, rising adoption of home dialysis options, improved survival rates of renal patients.
The artificial kidney market size is expected to see rapid growth in the next few years. It will grow to $21.18 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing investments in bioengineered kidney research, rising demand for portable dialysis solutions, expansion of remote patient monitoring, growing focus on reducing dialysis dependency, technological progress in artificial organ development. Major trends in the forecast period include increasing development of wearable dialysis systems, rising focus on implantable artificial kidney solutions, growing integration of smart monitoring in dialysis devices, expansion of home-based dialysis technologies, enhanced emphasis on patient mobility and comfort.
The sharp rise in chronic kidney disease cases is anticipated to accelerate the growth of the artificial kidney market in the coming years. Chronic kidney disease is a persistent medical condition in which kidney function progressively deteriorates over time. Artificial kidneys are widely used in the management of chronic kidney disease, as they help eliminate waste materials and toxins from the bloodstream, prevent fluid buildup, and maintain a healthy balance of electrolytes in the body. For example, in June 2023, Kidney Research UK reported that approximately 7.19 million people in the UK were living with chronic kidney disease in 2023, accounting for over 10% of the population, with projections indicating an increase to 7.61 million individuals by 2033. As a result, the growing prevalence of chronic kidney disease is contributing significantly to the expansion of the artificial kidney market.
Leading players in the artificial kidney market are increasingly prioritizing advanced solutions such as wearable sorbent-regeneration dialysis technologies to improve patient mobility, treatment adaptability, and overall quality of life. This technology employs a compact system that continuously purifies and recycles dialysate using sorbent cartridges, enabling portable and continuous dialysis, substantially lowering dialysate volume requirements, and allowing greater patient independence. For instance, in June 2023, AWAK Technologies, a medical technology firm based in Singapore, introduced AWAK PD, a wearable sorbent-regeneration peritoneal dialysis system developed to enable patients with end-stage kidney disease to receive dialysis while staying mobile. The device incorporates an ultra-lightweight three-kilogram design, a patented sorbent-based dialysate regeneration mechanism that cuts fluid usage by up to 90%, and a configuration recognized under the FDA Breakthrough Device program. AWAK PD enhances treatment convenience, supports patient mobility, and improves the overall dialysis experience.
In April 2023, M42, a tech-enabled healthcare company based in the United Arab Emirates, successfully acquired Diaverum for an undisclosed sum from Bridgepoint. This strategic acquisition positions M42 to extend its footprint in the healthcare sector, introduce innovative solutions to a global patient base, and leverage Diaverum's extensive network of clinics and patients specializing in dialysis services.
Major companies operating in the artificial kidney market are Fresenius SE and Co. KGaA, Medtronic plc, Asahi Kasei Medical Co. Ltd., Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Medical Corporation, Nikkiso Co. Ltd., Kawasumi Laboratories Inc., Quanta Dialysis Technologies Ltd., Triomed AB, WearOptimo, AWAK Technologies Pvt. Ltd., Aethlon Medical Inc., Blood Purification Technologies Inc., Xcorporeal Inc., Nanodialysis B.V., Neokidney Development BV, Wearable Medical Devices Inc., Nephria Bio Inc., US Kidney Research Corporation.
North America was the largest region in the artificial kidney market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial kidney market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial kidney market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the artificial kidney market by increasing costs of imported membranes, sensors, electronic control units, and biocompatible materials used in dialysis systems. Healthcare providers in North America and Europe are most affected due to reliance on imported medical components, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are increasing treatment equipment costs and slowing device upgrades. However, they are also promoting domestic manufacturing, localized component sourcing, and long-term innovation in artificial kidney technologies.
The artificial kidney market research report is one of a series of new reports that provides artificial kidney market statistics, including artificial kidney industry global market size, regional shares, competitors with a artificial kidney market share, detailed artificial kidney market segments, market trends and opportunities, and any further data you may need to thrive in the artificial kidney industry. This artificial kidney market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An artificial kidney is a mechanical device or system created to replicate the functions of a healthy kidney, specifically designed for individuals suffering from end-stage renal disease (ESRD) or kidney failure. Operating externally to the body, it serves as a substitute kidney by eliminating waste from circulation and regulating calcium ion absorption and red blood cell production.
The primary categories of artificial kidneys include wearable artificial kidneys and implantable artificial kidneys. Wearable artificial kidneys are portable devices worn by patients to simulate the functions of a natural kidney. This category encompasses methods such as hemodialysis, peritoneal dialysis, and combination approaches. The main end-users of artificial kidneys include hospitals, specialty clinics, ambulatory surgical centers, and other medical facilities.
The artificial kidney market consists of sales of peritoneal dialysis systems, hemodialysis artificial kidneys, dialysis membranes, filtration systems, pumping systems, bioartificial kidneys, dialysate compartments, and semipermeable hollow fibers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial kidney market size is expected to see rapid growth in the next few years. It will grow to $21.18 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing investments in bioengineered kidney research, rising demand for portable dialysis solutions, expansion of remote patient monitoring, growing focus on reducing dialysis dependency, technological progress in artificial organ development. Major trends in the forecast period include increasing development of wearable dialysis systems, rising focus on implantable artificial kidney solutions, growing integration of smart monitoring in dialysis devices, expansion of home-based dialysis technologies, enhanced emphasis on patient mobility and comfort.
The sharp rise in chronic kidney disease cases is anticipated to accelerate the growth of the artificial kidney market in the coming years. Chronic kidney disease is a persistent medical condition in which kidney function progressively deteriorates over time. Artificial kidneys are widely used in the management of chronic kidney disease, as they help eliminate waste materials and toxins from the bloodstream, prevent fluid buildup, and maintain a healthy balance of electrolytes in the body. For example, in June 2023, Kidney Research UK reported that approximately 7.19 million people in the UK were living with chronic kidney disease in 2023, accounting for over 10% of the population, with projections indicating an increase to 7.61 million individuals by 2033. As a result, the growing prevalence of chronic kidney disease is contributing significantly to the expansion of the artificial kidney market.
Leading players in the artificial kidney market are increasingly prioritizing advanced solutions such as wearable sorbent-regeneration dialysis technologies to improve patient mobility, treatment adaptability, and overall quality of life. This technology employs a compact system that continuously purifies and recycles dialysate using sorbent cartridges, enabling portable and continuous dialysis, substantially lowering dialysate volume requirements, and allowing greater patient independence. For instance, in June 2023, AWAK Technologies, a medical technology firm based in Singapore, introduced AWAK PD, a wearable sorbent-regeneration peritoneal dialysis system developed to enable patients with end-stage kidney disease to receive dialysis while staying mobile. The device incorporates an ultra-lightweight three-kilogram design, a patented sorbent-based dialysate regeneration mechanism that cuts fluid usage by up to 90%, and a configuration recognized under the FDA Breakthrough Device program. AWAK PD enhances treatment convenience, supports patient mobility, and improves the overall dialysis experience.
In April 2023, M42, a tech-enabled healthcare company based in the United Arab Emirates, successfully acquired Diaverum for an undisclosed sum from Bridgepoint. This strategic acquisition positions M42 to extend its footprint in the healthcare sector, introduce innovative solutions to a global patient base, and leverage Diaverum's extensive network of clinics and patients specializing in dialysis services.
Major companies operating in the artificial kidney market are Fresenius SE and Co. KGaA, Medtronic plc, Asahi Kasei Medical Co. Ltd., Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Medical Corporation, Nikkiso Co. Ltd., Kawasumi Laboratories Inc., Quanta Dialysis Technologies Ltd., Triomed AB, WearOptimo, AWAK Technologies Pvt. Ltd., Aethlon Medical Inc., Blood Purification Technologies Inc., Xcorporeal Inc., Nanodialysis B.V., Neokidney Development BV, Wearable Medical Devices Inc., Nephria Bio Inc., US Kidney Research Corporation.
North America was the largest region in the artificial kidney market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial kidney market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial kidney market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the artificial kidney market by increasing costs of imported membranes, sensors, electronic control units, and biocompatible materials used in dialysis systems. Healthcare providers in North America and Europe are most affected due to reliance on imported medical components, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are increasing treatment equipment costs and slowing device upgrades. However, they are also promoting domestic manufacturing, localized component sourcing, and long-term innovation in artificial kidney technologies.
The artificial kidney market research report is one of a series of new reports that provides artificial kidney market statistics, including artificial kidney industry global market size, regional shares, competitors with a artificial kidney market share, detailed artificial kidney market segments, market trends and opportunities, and any further data you may need to thrive in the artificial kidney industry. This artificial kidney market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An artificial kidney is a mechanical device or system created to replicate the functions of a healthy kidney, specifically designed for individuals suffering from end-stage renal disease (ESRD) or kidney failure. Operating externally to the body, it serves as a substitute kidney by eliminating waste from circulation and regulating calcium ion absorption and red blood cell production.
The primary categories of artificial kidneys include wearable artificial kidneys and implantable artificial kidneys. Wearable artificial kidneys are portable devices worn by patients to simulate the functions of a natural kidney. This category encompasses methods such as hemodialysis, peritoneal dialysis, and combination approaches. The main end-users of artificial kidneys include hospitals, specialty clinics, ambulatory surgical centers, and other medical facilities.
The artificial kidney market consists of sales of peritoneal dialysis systems, hemodialysis artificial kidneys, dialysis membranes, filtration systems, pumping systems, bioartificial kidneys, dialysate compartments, and semipermeable hollow fibers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Kidney Market Characteristics
3. Artificial Kidney Market Supply Chain Analysis
4. Global Artificial Kidney Market Trends and Strategies
5. Artificial Kidney Market Analysis of End Use Industries
7. Global Artificial Kidney Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Kidney Total Addressable Market (TAM) Analysis for the Market
9. Artificial Kidney Market Segmentation
10. Artificial Kidney Market Regional and Country Analysis
11. Asia-Pacific Artificial Kidney Market
12. China Artificial Kidney Market
13. India Artificial Kidney Market
14. Japan Artificial Kidney Market
15. Australia Artificial Kidney Market
16. Indonesia Artificial Kidney Market
17. South Korea Artificial Kidney Market
18. Taiwan Artificial Kidney Market
19. South East Asia Artificial Kidney Market
20. Western Europe Artificial Kidney Market
21. UK Artificial Kidney Market
22. Germany Artificial Kidney Market
23. France Artificial Kidney Market
24. Italy Artificial Kidney Market
25. Spain Artificial Kidney Market
26. Eastern Europe Artificial Kidney Market
27. Russia Artificial Kidney Market
28. North America Artificial Kidney Market
29. USA Artificial Kidney Market
30. Canada Artificial Kidney Market
31. South America Artificial Kidney Market
32. Brazil Artificial Kidney Market
33. Middle East Artificial Kidney Market
34. Africa Artificial Kidney Market
36. Artificial Kidney Market Competitive Landscape and Company Profiles
37. Artificial Kidney Market Other Major and Innovative Companies
40. Artificial Kidney Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Artificial Kidney Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial kidney market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial kidney? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial kidney market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Wearable Artificial Kidney; Implantable Artificial Kidney2) By Technology: Hemodialysis Systems; Peritoneal Dialysis Systems
3) By End-User: Hospitals; Specialty Clinics
Subsegments:
1) By Wearable Artificial Kidney: Portable Dialysis Systems; Compact Dialysis Units2) By Implantable Artificial Kidney: Bioengineered Kidneys; Hybrid Dialysis Systems
Companies Mentioned: Fresenius SE and Co. KGaA; Medtronic plc; Asahi Kasei Medical Co. Ltd.; Toray Industries Inc.; Baxter International Inc.; B. Braun Melsungen AG; Nipro Medical Corporation; Nikkiso Co. Ltd.; Kawasumi Laboratories Inc.; Quanta Dialysis Technologies Ltd.; Triomed AB; WearOptimo; AWAK Technologies Pvt. Ltd.; Aethlon Medical Inc.; Blood Purification Technologies Inc.; Xcorporeal Inc.; Nanodialysis B.V.; Neokidney Development BV; Wearable Medical Devices Inc.; Nephria Bio Inc.; US Kidney Research Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Artificial Kidney market report include:- Fresenius SE and Co. KGaA
- Medtronic plc
- Asahi Kasei Medical Co. Ltd.
- Toray Industries Inc.
- Baxter International Inc.
- B. Braun Melsungen AG
- Nipro Medical Corporation
- Nikkiso Co. Ltd.
- Kawasumi Laboratories Inc.
- Quanta Dialysis Technologies Ltd.
- Triomed AB
- WearOptimo
- AWAK Technologies Pvt. Ltd.
- Aethlon Medical Inc.
- Blood Purification Technologies Inc.
- Xcorporeal Inc.
- Nanodialysis B.V.
- Neokidney Development BV
- Wearable Medical Devices Inc.
- Nephria Bio Inc.
- US Kidney Research Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.91 Billion |
| Forecasted Market Value ( USD | $ 21.18 Billion |
| Compound Annual Growth Rate | 13.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
